A
What happened
Oura, a Finnish health tech firm, has successfully raised $900 million in a funding round led by Fidelity Management & Research Company, bringing its valuation to approximately $11 billion. This funding is intended to bolster Oura's efforts in AI and production innovation, as well as to introduce new health features and enhance global distribution. The company has sold over 5.5 million smart rings since its inception, with a significant portion of sales occurring in the past year. Oura's revenue more than doubled in 2024, reaching $500 million, and the company anticipates crossing the $1 billion sales mark this year. Oura's market share in the smart ring sector exceeds 80%, and it is attracting a diverse customer base, including younger women. Additionally, Oura has launched a new feature allowing users to book blood tests through its app, further expanding its health tech offerings.
★
Key insights
-
1
Significant funding secured
Oura raised $900 million to enhance its health tech capabilities.
-
2
Market leader in smart rings
Oura holds over 80% of the smart ring market share.
-
3
New health features introduced
The company launched a blood testing feature in its app.
-
4
Revenue growth expected
Oura anticipates sales to exceed $1 billion this year.
Takeaways
Oura's recent funding and strategic innovations position it strongly in the health tech market, enabling further growth and expansion of its product offerings.